CKD Bio Corp.
KRX:063160.KS
24200 (KRW) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 160,352.778 | 156,042.327 | 142,238.418 | 124,599.959 | 137,184.189 | 124,510.019 | 118,187.072 | 113,013.402 | 106,690.658 | 106,389.741 | 100,370.797 | 113,759.578 | 110,527.721 | 121,568.352 | 106,553.579 | 83,393.222 | 66,409.841 |
| Cost of Revenue
| 155,342.471 | 139,252.401 | 128,932.489 | 96,735.822 | 101,010.121 | 101,090.219 | 93,301.096 | 86,625.727 | 86,174.404 | 97,303.272 | 85,669.732 | 90,849.918 | 86,647.485 | 92,016.506 | 76,927.791 | 62,022.574 | 56,744.315 |
| Gross Profit
| 5,010.307 | 16,789.927 | 13,305.93 | 27,864.138 | 36,174.068 | 23,419.8 | 24,885.976 | 26,387.675 | 20,516.254 | 9,086.468 | 14,701.065 | 22,909.66 | 23,880.236 | 29,551.846 | 29,625.788 | 21,370.648 | 9,665.526 |
| Gross Profit Ratio
| 0.031 | 0.108 | 0.094 | 0.224 | 0.264 | 0.188 | 0.211 | 0.233 | 0.192 | 0.085 | 0.146 | 0.201 | 0.216 | 0.243 | 0.278 | 0.256 | 0.146 |
| Reseach & Development Expenses
| 12,684.808 | 15,431.867 | 11,516.023 | 9,117.523 | 10,704.204 | 7,880.824 | 6,669.75 | 5,619.958 | 4,055.98 | 3,532.826 | 3,533.127 | 3,267.007 | 3,261.705 | 3,320.265 | 2,694.072 | 1,737.069 | 1,960.155 |
| General & Administrative Expenses
| 3,322.583 | 5,781.059 | 3,953.696 | 3,553.904 | 1,764.759 | 1,178.223 | 556.301 | 1,019.26 | 468.79 | 469.498 | 795.463 | 554.897 | 554.461 | 256.543 | 302.208 | 256.307 | 304.625 |
| Selling & Marketing Expenses
| 3,263.507 | 3,355.047 | 2,989.455 | 2,596.073 | 3,502.143 | 2,548.483 | 4,304.171 | 3,980.672 | 3,997.112 | 4,127.809 | 4,766.52 | 6,562.332 | 6,766.707 | 6,188.689 | 6,126.967 | 4,765.523 | 3,782.457 |
| SG&A
| 12,511.02 | 9,136.106 | 6,943.151 | 6,149.977 | 5,266.902 | 3,726.706 | 4,860.472 | 4,999.932 | 4,465.902 | 4,597.307 | 5,561.983 | 7,117.229 | 7,321.168 | 6,445.232 | 6,429.175 | 5,021.83 | 4,087.082 |
| Other Expenses
| 108.012 | 7,032.297 | 6,279.025 | 4,989.615 | 4,790.388 | 1,415.388 | 549.451 | 743.588 | 291.988 | 438.094 | 833.731 | 985.875 | -772.12 | 110.847 | 402.539 | -73.114 | -586.431 |
| Operating Expenses
| 25,195.828 | 31,600.27 | 24,738.199 | 20,257.115 | 20,761.494 | 16,410.816 | 15,853.273 | 14,771.752 | 12,474.062 | 11,727.961 | 12,752.508 | 14,110.411 | 9,810.753 | 13,380.886 | 12,307.924 | 13,767.38 | 9,280.127 |
| Operating Income
| -20,185.52 | -14,770.072 | -9,810.367 | 7,607.022 | 15,412.574 | 7,008.984 | 9,032.703 | 11,615.924 | 8,042.193 | -2,641.493 | 1,948.557 | 8,799.249 | 13,544.619 | 16,170.959 | 17,089.739 | 7,603.269 | 385.4 |
| Operating Income Ratio
| -0.126 | -0.095 | -0.069 | 0.061 | 0.112 | 0.056 | 0.076 | 0.103 | 0.075 | -0.025 | 0.019 | 0.077 | 0.123 | 0.133 | 0.16 | 0.091 | 0.006 |
| Total Other Income Expenses Net
| -4,011.098 | -3,819.789 | -3,547.28 | -547.645 | 225.741 | 2,285.931 | 608.418 | 496.545 | 61.037 | 702.89 | -45.345 | -680.659 | -1,087.798 | -366.713 | -260.066 | 2,274.035 | -4,924.677 |
| Income Before Tax
| -24,196.618 | -18,589.861 | -13,357.647 | 7,059.376 | 15,638.314 | 9,294.916 | 9,641.121 | 12,112.468 | 8,103.229 | -1,938.603 | 1,903.213 | 8,118.59 | 12,981.685 | 15,804.247 | 16,829.674 | 9,877.303 | -4,539.278 |
| Income Before Tax Ratio
| -0.151 | -0.119 | -0.094 | 0.057 | 0.114 | 0.075 | 0.082 | 0.107 | 0.076 | -0.018 | 0.019 | 0.071 | 0.117 | 0.13 | 0.158 | 0.118 | -0.068 |
| Income Tax Expense
| -4.098 | -1,887.245 | -6,781.046 | 851.978 | 3,373.434 | 1,338.728 | 1,624.822 | 2,677.854 | 1,450.096 | -833.553 | 245.764 | 1,017.3 | 2,061.089 | 1,428.535 | 645.745 | 1,139.674 | -1,265.886 |
| Net Income
| -24,192.52 | -16,702.616 | -6,576.601 | 6,207.398 | 12,264.88 | 7,956.187 | 8,016.299 | 9,434.615 | 6,653.133 | -1,105.05 | 1,657.449 | 7,101.29 | 10,920.596 | 14,375.712 | 16,183.929 | 8,737.629 | -3,273.392 |
| Net Income Ratio
| -0.151 | -0.107 | -0.046 | 0.05 | 0.089 | 0.064 | 0.068 | 0.083 | 0.062 | -0.01 | 0.017 | 0.062 | 0.099 | 0.118 | 0.152 | 0.105 | -0.049 |
| EPS
| -4,409.9 | -3,044.61 | -1,198.81 | 1,147.3 | 2,391.06 | 1,477.21 | 1,563 | 1,839 | 1,297 | -215 | 323 | 1,384 | 2,129 | 2,618.1 | 2,947.62 | 1,591.43 | -626 |
| EPS Diluted
| -4,409.9 | -3,044.61 | -1,198.81 | 1,147.3 | 2,391.06 | 1,477.14 | 1,563 | 1,839 | 1,297 | -215 | 323 | 1,384 | 2,129 | 2,618.1 | 2,947.62 | 1,591.43 | -626 |
| EBITDA
| -2,607.919 | 3,168.187 | 7,173.828 | 18,859.07 | 26,621.301 | 18,546.005 | 17,570.011 | 21,343.429 | 19,969.477 | 9,837.466 | 14,306.276 | 20,894.16 | 23,987.623 | 26,824.848 | 23,419.471 | 15,800.039 | 2,983.095 |
| EBITDA Ratio
| -0.016 | 0.02 | 0.05 | 0.151 | 0.194 | 0.149 | 0.149 | 0.189 | 0.187 | 0.092 | 0.143 | 0.184 | 0.217 | 0.221 | 0.22 | 0.189 | 0.045 |